Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of RQC for AMD [Phase 2]
The document reports the completion of a Phase 2 trial evaluating the safety and efficacy of RQC for age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Intravitreal Faricimab in Patients With Refractory Macular Edema [Phase 2]
Phase 2 trial update evaluating intravitreal faricimab for refractory macular edema in age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period [Phase 4]
Phase 4 trial comparing post-intravitreal injection pain scores when using loteprednol etabonate, bromfenac sodium, or artificial tears in p…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration
This clinical trial investigates how artificial lighting affects visual capacity in patients with age-related macular degeneration; recruitm…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Sildenafil for Treatment of Choroidal Ischemia [Phase 2]
This is a completed Phase 2 trial evaluating sildenafil for choroidal ischemia, with results posted in 2025; the study also involves vitelli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration [Phase 2]
A masked, placebo-controlled Phase 2 trial of iptacopan for age-related macular degeneration is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) [NA]
This clinical trial update notes the completion of a study evaluating microcurrent stimulation therapy for dry, nonexudative age-related mac…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Implantation of SML in Patients With Dry Age-related Macular Degeneration and Myopic Maculopathy [NA]
Clinical trial update reports the completed study evaluating implantation of SML in patients with dry age-related macular degeneration and m…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy [NA]
A completed clinical trial comparing Clarus and Optos ultrawide-field imaging systems for geographic atrophy in age-related macular degenera…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of ranibizumab 10 mg/mL injections for diabetic macular edema is currently recru…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Phase 1 Safety Study of ALK-001 in Healthy Volunteers [Phase 1]
Phase 1 safety study of ALK-001 in healthy volunteers has completed, assessing safety in humans. It targets retinal degenerative conditions …
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration [Phase 1]
Phase 1 dose-escalation trial evaluating IBI302 in patients with age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION [Phase 1]
Phase 1 trial update on the safety of cultured allogeneic umbilical cord-derived mesenchymal stem cells for non-arteritic anterior ischemic …
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD). [Phase 2]
A Phase 2 trial evaluating oral CT1812 in geographic atrophy secondary to dry age-related macular degeneration has been terminated; no effic…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Laser Intervention in Early Age-Related Macular Degeneration Study [NA]
The trial evaluating laser intervention for early age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study [NA]
A clinical trial evaluating subthreshold laser treatment for intermediate age-related macular degeneration with nascent geographic atrophy h…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59 [Phase 1]
Phase 1 clinical trial evaluating AAVCAGsCD59 for advanced dry age-related macular degeneration has completed. The study was sponsored by Ja…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration [Phase 2]
Phase 2 trial update of an Encapsulated Cell Technology implant for atrophic (dry) age-related macular degeneration; the study has completed…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients [EARLY_Phase 1]
Phase 1 trial evaluating oral curcumin supplementation in dry age-related macular degeneration; study completed.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of ONS-5010 in neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders [Phase 3]
A 3-month Phase 3 safety study of ONS-5010 in subjects with visual impairment due to retinal disorders has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) [Phase 3]
Phase 3 clinical effectiveness study of ONS-5010 for neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Change in Ocular Perfusion After Intravitreal Anti-VEGF in Patients with Age-related Maculopathy or Diabetic Macula Edema
A completed clinical trial reports a change in ocular perfusion after intravitreal anti-VEGF therapy in patients with age-related macular de…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study of ARC1905 (Anti-C5 Aptamer) in Subjects With Dry Age-related Macular Degeneration [Phase 1]
Phase 1 study of ARC1905, an anti-C5 aptamer, for dry age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 study to assess safety and efficacy of multiple doses of IONIS-FB-LRx in geographic atrophy due to age-related macular degeneration;…